At my previous internship, the senior associate was skeptical about investing in a late‑stage SaaS startup due to perceived market saturation.

I needed to convince him that the company’s unique pricing model and high net‑retention rate justified a deeper look.

I compiled a comparative analysis, highlighted the differentiated product features, and presented a 3‑year financial projection showing a 35% IRR. I also arranged a call with the startup’s CFO to address technical concerns.

The associate approved a $2M pilot investment, which later contributed to a successful Series B round and a 4x return for the fund.

During a summer research project, I noticed a surge in API‑first platforms among fintech startups.

My goal was to assess whether this trend could generate early‑stage investment opportunities for the firm.

I scraped funding data from Crunchbase, conducted interviews with founders, and built a trend index showing a 150% YoY increase in API‑first funding.

The team added three API‑focused startups to the pipeline, two of which secured seed rounds and are now in our portfolio.

After presenting a due‑diligence report on a biotech startup, my manager pointed out that I had overlooked regulatory risk timelines.

I needed to address the gap and improve the report’s completeness.

I scheduled a follow‑up meeting, incorporated a detailed regulatory pathway analysis, and added a risk mitigation section with timelines and contingency plans.

The revised report received approval, and the investment committee proceeded with a $5M commitment, citing the thorough risk assessment.

At my previous role, I was tasked with valuing a pre‑revenue AI startup for a potential seed investment.

Create a full three‑statement model to estimate enterprise value and assess dilution scenarios.

I projected revenue based on TAM growth, built cost assumptions, linked income statement to balance sheet and cash flow, incorporated a 20% discount rate for DCF, and ran sensitivity analysis on churn and CAC.

The model indicated a post‑money valuation of $12M, which the partners used to negotiate a 12% equity stake, later resulting in a 3x return at Series A.

During due diligence on a fintech startup, the team’s background was a key risk factor.

Develop a framework to evaluate management capability and alignment with the fund’s thesis.

I created a scoring matrix covering track record, domain expertise, network, governance practices, and cultural fit. I conducted reference checks and compared past exits.

The matrix highlighted gaps in governance, leading us to negotiate board observer rights before investing, which later helped steer strategic pivots.

A portfolio company wanted to expand into a niche B2B SaaS market for supply‑chain visibility.

Provide a top‑down market size estimate to guide product roadmap and fundraising targets.

I started with total addressable market (TAM) using industry reports, applied a serviceable obtainable market (SOM) filter based on target customer size, and built a revenue model using average contract value and adoption rates. I validated assumptions with expert interviews.

The analysis projected a $250M TAM with a $30M SOM over five years, supporting a $10M Series A raise and informing the product’s feature prioritization.

During a screening call, the startup presented a deck claiming a 200% YoY growth in user adoption.

Critically evaluate the deck to uncover potential risks before advancing to due diligence.

I noted (1) lack of disclosed churn rates, (2) overly optimistic revenue projections without clear pricing strategy, and (3) limited regulatory compliance details for HIPAA. I recommended requesting detailed churn data, a pricing model breakdown, and a compliance audit report before proceeding.

The startup provided the missing data, revealing a 12% churn and a revised revenue forecast, leading us to adjust the valuation down by 15% and negotiate better terms.

Our portfolio fintech had the opportunity to acquire a smaller competitor with complementary API capabilities.

Develop an evaluation framework to advise the board on the acquisition’s merits.

I built an accretion/dilution model, assessed synergies (cost savings, cross‑sell revenue), performed a strategic fit analysis (product overlap, market expansion), and ran a sensitivity analysis on integration risk and financing structure.

The analysis showed a 5% EPS accretion and $8M annual synergies, leading the board to approve the $25M cash deal, which later increased ARR by 30% within a year.

Our seed fund needed a scalable way to triage 200+ AI startup submissions per quarter.

Create a concise, high‑impact screening rubric that aligns with the fund’s thesis on AI‑driven productivity tools.

I developed a 5‑point rubric covering (1) problem relevance, (2) uniqueness of AI solution, (3) founding team expertise, (4) TAM > $1B, (5) preliminary unit economics (CAC vs LTV). Each point scored 0‑2, with a threshold of 7/10 to move to full diligence.

The rubric reduced full‑diligence workload by 60% while maintaining a 45% investment success rate, leading to three seed deals that collectively achieved 4x returns within 18 months.